Innocan Pharma Corp. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€0.31
Target price
23.01.22
€6.00
Performance (%)
33.11%
End price
24.01.22
€0.41
Summary
This prediction ended on 24.01.22 with a price of €0.41. The BUY prediction by Maxi_Scalibusa for Innocan Pharma Corp. saw massive gains of 33.11%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% | 68.731% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% | 113.533% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% | 50.934% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% | 68.205% |
According to Maxi_Scalibusa what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Innocan Pharma Corp. diskutieren
In the thread Trading Innocan Pharma Corp.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten